Phoenix, AZ -- (ReleaseWire) -- 09/02/2014 -- Dr. Michael Fitzmaurice of Fitzmaurice Hand Institute joined Money Radio (1550 AM and 99.3 FM) for Doctor Talk on Saturday August 16th at 1:00pm to discuss his work with stem cells and regenerative medicine and the endless possibilities using for hand and wrist treatment using these progressive therapies.

Dr. Michael Fitzmaurice is a leader in minimally invasive hand surgery in Phoenix. He is heavily involved in the use of and research of stem cells and regenerative medicine. Having pioneered a minimally invasive technique known as EndoView™, Dr. Fitzmaurice is always on the hunt for bigger and better alternatives to traditional hand and wrist medicine.

About The Fitzmaurice Hand Institute
The philosophy behind The Fitzmaurice Hand Institute is a simple one: Strive to always provide the best, most appropriate and most effective care for each and every person who walks through our door.

For Dr. Michael Fitzmaurice, this is an all-encompassing principle that guides everything he does in the office and in the operating room. It also is the guiding premise behind our unique level of compassion, commitment and service. And it's the very heart of his approach to your fastest, most complete relief and return to full function — the minimally invasive approach.

The Fitzmaurice Hand Institute
19820 N 7th St #115
Phoenix, AZ 85024
480-719-4750
fitzhand.com

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

Phoenix, AZ -- (ReleaseWire) -- 06/25/2014 -- Wouldn't it be nice to have a concierge level option when it comes to your health care? At the The Fitzmaurice Hand Institute you can. They're introducing an extremely affordable new cash pricing payment option that eliminates the middleman and gives patients extra benefits.

Forget about filling out piles of insurance forms or paying high deductibles. With their new cash pricing payment option, they've eliminated all of those barriers. For patients, this means immediate care at a price significantly lower than the standard deductible rate. And, as an added bonus, patients who choose the cash pricing option receive additional consultation services through Telemedicine, a HIPAA-compliant software system, similar to Skype, that allows users to communicate through video.

Insurance or no insurance, they've simplified the process so that patients have one direct low payment for all of their health care costs, including a full examination, diagnosis workup, X-ray, ultrasound, surgeon fees, and surgical center fees, which will vary depending on the chosen facility.

Patients will know upfront how much they're expected to pay, and they can return home burden free to focus on what matters most: their health.

The Fitzmaurice Hand Institute even provides a payment plan option for those who need it. In short, they've designed their cash pricing model to meet a wide range of needs.

One payment, multiple services, no surprises - it's health care made for everyone.

About The Fitzmaurice Hand Institute
The philosophy behind The Fitzmaurice Hand Institute is a simple one: Strive to always provide the best, most appropriate and most effective care for each and every person who walks through our door.

For Dr. Michael Fitzmaurice, this is an all-encompassing principle that guides everything he does in the office and in the operating room. It also is the guiding premise behind our unique level of compassion, commitment and service. And it's the very heart of his approach to your fastest, most complete relief and return to full function — the minimally invasive approach.

The Fitzmaurice Hand Institute
19820 N 7th St #115 Phoenix, AZ 85024
(480) 428-1754
fitzhand.com

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

Phoenix, AZ -- (ReleaseWire) -- 05/09/2014 -- The Fitzmaurice Hand Institute is proud to announce a new, cutting-edge minimally invasive system for treating carpal tunnel syndrome created by our very own Dr. Michael Fitzmaurice. EndoNerve™ Endoscopic Carpal Tunnel Release is a revolutionary, patent-pending treatment that uses special instrumentation in addition to a one-of-a-kind supplement, which, when combined, dramatically reduce the risks and recovery time associated with carpal tunnel surgery.

After years spent performing typical endoscopic surgeries, Dr. Fitzmaurice recognized a need for a more advanced procedure and designed the EndoNerve™ Endoscopic Carpal Tunnel Release to meet that need.

"I'm never satisfied as a surgeon. I'm always looking to improve what's out there," said Dr. Fitzmaurice in regards to the development of this new technology.

Unlike traditional endoscopic procedures, the EndoNerve™ Endoscopic Carpal Tunnel Release uses smaller instruments and increases visibility, allowing the surgeon to see all of the structures as he is doing the procedure, including the nerve, tendon, and ligament. The smaller instruments and improved visibility help to minimize injuries and decrease recovery time.

Treatment is further enhanced by NeuroGen®, a nerve supplement also created by Dr. Fitzmaurice that has been proven through scientific research to improve nerve regeneration, decrease nerve pain, and decrease swelling. While traditional endoscopic surgeries have a recovery time of 20 days, the average recovery time for patients who undergo the EndoNerve™ Endoscopic Carpal Tunnel Release and use NeuroGen afterward is significantly reduced to only six days.

To read more about this groundbreaking surgical advancement, please click here.

About Dr. Fitzmaurice
Dr. Fitzmaurice is among the most experienced minimally invasive hand surgeons in the world, and he has performed more than 3000 endoscopic carpal tunnel surgeries with a 99% success rate. He's treated thousands of patients from Phoenix, Scottsdale, Mesa, Tempe, Gilbert, Peoria and other areas of Arizona. If you would like to schedule an appointment at The Fitzmaurice Hand Institute in Phoenix, please contact our office.

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm